SL
ALXN

Savior LLC’s Alexion Pharmaceuticals ALXN Stock Holding History

Savior LLC’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-96
Closed -$18K – 870
2021
Q2 		$18K Sell
96
-41
-30% -$7.04K 0.02% 308
2021
Q1 		$21K Hold
137
– – 0.02% 282
2020
Q4 		$21K Hold
137
– – 0.02% 282
2020
Q3 		$16K Sell
137
-45
-25% -$4.86K 0.02% 293
2020
Q2 		$20K Buy
182
+86
+90% +$9.13K 0.03% 237
2020
Q1 		$9K Sell
96
-118
-55% -$11.6K 0.01% 349
2019
Q4 		$23K Buy
+214
New +$22.9K 0.03% 277

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return